Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.

Manufacturing issues are the latest problem for Ultragenyx Pharmaceutical Inc. to solve after last week’s disappointment in a phase III study to treat brittle bones. The U.S. FDA gave the company a ...

KenvueKVUE stock yo-yoed Monday after the down-and-out health care player — known for brands like Aveeno, Band-Aid and ...

Capricor plans to resubmit its application for the approval of deramiocel for DMD after the FDA declined to accept the ...